Do endocrinologists use the Insulin-like Growth Factor 1 (IgF-1) lab result number, the z score, or both to interpret labs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of IGF-1 Lab Results in Endocrinology Practice

Endocrinologists use both the absolute IGF-1 lab result number and the age/sex-specific z-score (or SDS - standard deviation score) to interpret IGF-1 labs, with the z-score being particularly important for accurate clinical interpretation.

Primary Considerations for IGF-1 Interpretation

  • Z-scores/SDS values: Essential for accurate interpretation as IGF-1 levels vary significantly with age and sex
  • Absolute values: Used alongside z-scores, particularly when evaluating for specific cutoff thresholds

Clinical Importance of Z-Scores

Z-scores provide critical context for IGF-1 interpretation because:

  • IGF-1 levels naturally decline with age
  • Sex-specific variations exist in normal ranges
  • Z-scores standardize results across different populations and laboratories 1

Disease-Specific Interpretation Approaches

For Acromegaly

  • Primary diagnostic approach: IGF-1 elevation (typically with z-score >+2.0) is sufficient for diagnosis in most clinically suspected cases 2
  • Confirmatory testing: OGTT (oral glucose tolerance test) may be used when IGF-1 elevation is modest (less than twice upper limit of normal) with equivocal clinical features 2
  • Treatment monitoring: Both absolute IGF-1 values and z-scores are used to track treatment efficacy 3

For Growth Hormone Deficiency

  • Screening approach: IGF-1 z-scores are more valuable than absolute values, but neither is sufficient alone for diagnosis 4
  • Diagnostic threshold: Very low IGF-1 levels (z-score <-3 in adults over age 28) in the context of documented pituitary disease suggest high probability of GH deficiency 4
  • Multiple deficiencies: In patients with two or more additional pituitary hormone deficiencies, severely low IGF-1 has 99% probability of indicating GH deficiency 4

Pitfalls in IGF-1 Interpretation

  1. Non-linearity with GH levels: The relationship between GH and IGF-1 is not linear, particularly at GH levels above 1 ng/ml 3
  2. Confounding factors: IGF-1 levels are affected by:
    • Nutritional status (decreased in malnutrition)
    • Thyroid function (decreased in hypothyroidism)
    • Liver disease (altered production)
    • Energy availability (decreased in low energy states) 1
  3. Assay variability: Different laboratories use different assays with varying reference ranges, making standardization challenging

Special Populations

Athletes and Female Athlete Triad

  • Low IGF-1 is a marker of low energy availability in female athletes 1
  • Monitoring both absolute values and z-scores helps assess metabolic status and response to nutritional interventions

Post-Traumatic Brain Injury

  • IGF-1 levels alone (even as z-scores) have poor utility as screening tools for GH deficiency following TBI 5
  • Dynamic GH stimulation testing remains necessary despite normal IGF-1 levels

Best Practice Approach

  1. Always interpret IGF-1 with age/sex-specific z-scores
  2. Consider clinical context and pre-test probability of disease
  3. Use confirmatory testing (GH stimulation tests or OGTT) when indicated
  4. Monitor trends over time rather than isolated values when assessing treatment response
  5. Account for confounding factors that may alter IGF-1 independent of GH status

This approach ensures the most accurate clinical interpretation of IGF-1 results and appropriate patient management decisions.

References

Guideline

Insulin-Like Growth Factor 1 (IGF-1) Physiology and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.